DOI QR코드

DOI QR Code

Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210

  • Cha, Hye Jin (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Seong, Yeon-Hee (Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Chungbuk National University) ;
  • Song, Min-Ji (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Jeong, Ho-Sang (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Shin, Jisoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Yun, Jaesuk (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Han, Kyoungmoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Kim, Young-Hoon (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Kang, Hoil (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety) ;
  • Kim, Hyoung Soo (Pharmacological Research Division, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety)
  • Received : 2015.05.22
  • Accepted : 2015.07.07
  • Published : 2015.11.01

Abstract

Synthetic cannabinoids JWH-018 and JWH-250 in 'herbal incense' also called 'spice' were first introduced in many countries. Numerous synthetic cannabinoids with similar chemical structures emerged simultaneously and suddenly. Currently there are not sufficient data on their adverse effects including neurotoxicity. There are only anecdotal reports that suggest their toxicity. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). In functional observation battery (FOB) test, animals treated with 5 mg/kg of JWH-081 or JWH-210 showed traction and tremor. Their locomotor activities and rotarod retention time were significantly (p<0.05) decreased. However, no significant change was observed in learning or memory function. In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicity. Our results suggest that JWH-081 and JWH-210 may be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens. To confirm our findings, further studies are needed in the future.

Keywords

References

  1. Auwarter, V., Dresen, S., Weinmann, W., Muller, M., Putz, M. and Rerreiros, N. (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 44, 832-837. https://doi.org/10.1002/jms.1558
  2. Boucard, A., Betat, A. M., Forster, R., Simonard, A. and Forger, G. (2010) Evaluation of neurotoxicity potential in rats: the functional observational battery. In Current Protocols in Pharmacology (Enna, S. J. & Williams, M. Ed.), Ch 10, Unit 10, 12, John Wiley & Sons, Inc., New Jersey.
  3. Cha, H. J., Lee, K. W., Song, M. J., Hyeon, Y. J., Jang, C. G., Ahn, J. I., Jeon, S. H., Kim, H. U., Kim, Y. H., Seong, W. K., Kang, H., Yoo, H. S. and Jeong, H. S. (2014) Dependence potential of the synthetic cannabinoids JWH-073, JWH-081, and JWH-210: in vivo and in vitro approaches. Biomol. Ther. 22, 363-369. https://doi.org/10.4062/biomolther.2014.039
  4. Chaperon, F. Soubrie, P., Puech, A. J. and Thiebot, M. H. (1998) Involvement of central cannabinoid (CB) receptors in the establishment of place conditioning in rats. Psychopharmacology 135, 324-332. https://doi.org/10.1007/s002130050518
  5. Cheer, J. F., Kendall, D. A. and Marsden, C. A. (2000) Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology 151, 25-30. https://doi.org/10.1007/s002130000481
  6. Cohen, J., Morrison, S., Greenberg, J. and Saidinejad, M. (2012) Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics 129, e1064-1067. https://doi.org/10.1542/peds.2011-2567
  7. Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R. and Martin, B. R. (1993) Cannabinoid structureactivity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265, 218-226.
  8. Corcoran, M. E. and Amit, Z. (1974) Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacologia 35, 129-147. https://doi.org/10.1007/BF00429580
  9. Fattore, L., Cossu, G., Martellotta, C. M. and Fratta, W. (2001) Intravenous self-administration of the cannabinoids CB receptor agonist WIN 55, 212-2 in rats. Psychopharmacology 156, 410-416. https://doi.org/10.1007/s002130100734
  10. Harris, C. R. and Brown, A. (2013) Synthetic cannabinoid intoxication: a case series and review. J. Emerg. Med. 44, 360-366. https://doi.org/10.1016/j.jemermed.2012.07.061
  11. Harris, R. T., Waters, W. and McLendon, D. (1974) Evaluation of reinforcing capability of ${\Delta}$9-tetrahydrocannabinol in rhesus monkeys. Psychopharmacology 37, 23-29. https://doi.org/10.1007/BF00426679
  12. Hermanns-Clausen, M., Kneisel, Cl, Szabo, B. and Auwarter, V. (2013) Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108, 534-544. https://doi.org/10.1111/j.1360-0443.2012.04078.x
  13. Hutcheson, D., Tzavara, E., Th Smadja, C. Vlijent, E., Roques, B., Hanoune, J. and Maldonado, R. (1998) Behavioral and biochemical evidence for signs of abstinence in mice chronically treated with ${\Delta}$9-tetrahydrocannabinol. Br. J. Pharmacol. 125, 1567-1577. https://doi.org/10.1038/sj.bjp.0702228
  14. Leite, J. R. and Culini, E. A. (1974) Failure to obtain cannabis-directed behavior and abstinence syndrome in rats chronically treated with Cannabis sativa extracts. Psychopharmacology 36, 133-145. https://doi.org/10.1007/BF00421785
  15. Martellota, M. C., Cossu, G., Fattore, L., Gessa, G. L. and Fratta, W. (1998) Self-administration of the cannabinoid receptor agonist WIN 55-212, 2 in drug-naive mice. Neuroscience 85, 327-330. https://doi.org/10.1016/S0306-4522(98)00052-9
  16. McGuinness, T. M. and Newell, D. (2012) Risky recreation: synthetic cannabinoids have dangerous effects. J. Psychosoc. Nurs. Ment. Health Serv. 50, 16-18.
  17. Moser, V. C. (1989) Screening approaches to neurotoxicity: a functional observational battery. J. Am. Coll. Toxicol. 8, 85-94. https://doi.org/10.3109/10915818909009095
  18. O'Callaghan, J. P., Daughtrey, W. C., Clark, C. R., Schreiner, C. A. and White, R. (2014) Health assessment of gasoline and fuel oxygenate vapors: neurotoxicity evaluation. Regul. Toxicol. Pharmacol. 70, S35-42. https://doi.org/10.1016/j.yrtph.2014.05.002
  19. Piggee, C. (2009) Investigating a not-so-natural high. Anal. Chem. 81, 3205-3207. https://doi.org/10.1021/ac900564u
  20. Porter, A. C. and Felder, C. C. (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol. Ther. 90, 45-60. https://doi.org/10.1016/S0163-7258(01)00130-9
  21. Vlachou, S., Nomikos, G. G. and Panagis, G. (2005) CB cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology 179, 498-508. https://doi.org/10.1007/s00213-004-2050-0
  22. Wiley, J. L., Marusich, J. A., Martin, B. R. and Huffman, J. W. (2011) 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice. Drug Alcohol Depend. 123, 148-153.

Cited by

  1. Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies vol.32, pp.3, 2017, https://doi.org/10.1002/hup.2601
  2. Buzz Juice: Neurological sequelae of synthetic cannabinoids vol.37, 2017, https://doi.org/10.1016/j.jocn.2016.10.046
  3. Cannabinoïdes de synthèse : une nouvelle matrice des addictions vol.46, pp.1, 2017, https://doi.org/10.1016/j.lpm.2016.11.014
  4. Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats vol.12, pp.1662-453X, 2018, https://doi.org/10.3389/fnins.2018.00703
  5. Targeted and non-targeted metabolite identification of MAM-2201 in human, mouse, and rat hepatocytes vol.10, pp.8, 2018, https://doi.org/10.1002/dta.2389
  6. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists vol.134, pp.1, 2015, https://doi.org/10.1016/j.neuropharm.2017.10.041
  7. Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy vol.56, pp.1, 2020, https://doi.org/10.3390/medicina56010024